Want to see TSE:AIDX full AI Analyst Report?
AIDX Stock Chart & Stats
C$0.76
C$0.00(0.00%)
At close: 4:00 PM EDT
C$0.76
C$0.00(0.00%)
Day’s Range― - ―
52-Week RangeC$0.58 - C$1.61
Previous CloseN/A
Volume263.16K
Average Volume (3M)210.67K
Market Cap
C$258.38M
Enterprise ValueC$287.49
Total Cash (Recent Filing)C$39.81M
Total Debt (Recent Filing)C$84.51M
Price to Earnings (P/E)―
Beta0.90
Next Earnings
Nov 16, 2026EPS Estimate
-0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.13
Shares Outstanding304,754,880
10 Day Avg. Volume165,628
30 Day Avg. Volume210,666
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)1.70
Price to Sales (P/S)2.03
P/FCF Ratio-10.44
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$1.88Price Target Upside146.71% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)-0.05
Revenue Forecast (FY)C$135.86M
Bulls Say, Bears Say
Bulls Say
Strong Revenue ScalingThe sharp first-half revenue increase shows that Orion has materially expanded HEALWELL AI’s operating scale and commercial base. A larger platform can support broader cross-selling, improve fixed-cost absorption, and create a stronger foundation for recurring healthcare software growth.
Large Clinical Data PlatformExtensive patient data, clinician reach, and demonstrated screening activity provide meaningful platform scale and clinical validation. These assets can strengthen product usefulness, support provider adoption, and create durable advantages as AI tools become more embedded in care workflows.
Progress Toward Recurring Enterprise ModelThe shift from smaller pilots toward larger enterprise licenses could improve revenue durability and customer retention if deployments convert successfully. Cross-selling across the Orion base also offers an efficient route to expansion by increasing value from existing healthcare relationships.
Bears Say
Persistent Losses And Cash BurnHEALWELL AI has not yet reached self-funding operations, as continuing losses and negative free cash flow require sustained execution before growth can translate into durable financial strength. This limits internal funding capacity and leaves less flexibility if profitability improvement is delayed.
Long Enterprise Sales CyclesLong sales cycles can defer contract wins, implementations, and revenue recognition, making growth less predictable over the next several quarters. They also raise execution demands because the company must maintain investment and customer engagement for longer before realizing enterprise economics.
Incomplete Integration SynergiesThe Orion integration has delivered revenue benefits faster than cost and margin improvements, leaving a meaningful portion of the expected efficiency opportunity unrealized. Until technology debt reduction and R&D consolidation progress, profitability and margin expansion may remain uneven.
HEALWELL AI News
AIDX FAQ
What was HEALWELL AI’s price range in the past 12 months?
HEALWELL AI lowest stock price was C$0.58 and its highest was C$1.61 in the past 12 months.
What is HEALWELL AI’s market cap?
HEALWELL AI’s market cap is C$258.38M.
When is HEALWELL AI’s upcoming earnings report date?
HEALWELL AI’s upcoming earnings report date is Nov 16, 2026 which is in 61 days.
How were HEALWELL AI’s earnings last quarter?
HEALWELL AI released its earnings results on Aug 07, 2026. The company reported C$0.02 earnings per share for the quarter, beating the consensus estimate of -C$0.025 by C$0.045.
Is HEALWELL AI overvalued?
According to Wall Street analysts HEALWELL AI’s price is currently Undervalued.
Does HEALWELL AI pay dividends?
HEALWELL AI does not currently pay dividends.
What is HEALWELL AI’s EPS estimate?
HEALWELL AI’s EPS estimate is -0.03.
How many shares outstanding does HEALWELL AI have?
HEALWELL AI has 304,754,880 shares outstanding.
What happened to HEALWELL AI’s price movement after its last earnings report?
HEALWELL AI reported an EPS of C$0.02 in its last earnings report, beating expectations of -C$0.025. Following the earnings report the stock price went down -4.286%.
Which hedge fund is a major shareholder of HEALWELL AI?
Currently, no hedge funds are holding shares in TSE:AIDX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
HEALWELL AI Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
C$1.88 (146.71% Upside)
C$1.88 (146.71% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 0.9%
Last 30 Days ▼ 0.9%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-41.86%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-10.58%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
HEALWELL AI
Healwell AI Inc., a Toronto-based healthcare technology firm established in 2012, specializes in leveraging artificial intelligence and data science to advance preventative medical care. The company develops an AI-powered platform designed to assist healthcare providers with crucial decision-making. They maintain a significant strategic partnership with WELL Health Technologies Corp., focusing on accelerating the expansion and innovation of AI-driven healthcare solutions. Prior to its current name, adopted in October 2023, the organization was known as MCI Onehealth Technologies Inc.
AIDX Stock 12 Month Forecast
Average Price Target
C$1.88
▲(146.71% Upside)
Technical Analysis
Cardiocomm Solutions
―
Reliq Health Technologies
―
Leveljump Healthcare Corp.
―
Kovo HealthTech Corporation
―
Hydreight Technologies Inc
―